Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management

27 Apr, 2021

Glytec Raises $21 Million To Set the Standard for Hospital Insulin Dosing and Glycemic Management
Photo by Maliha Mannan on Unsplash

– Glytec announced $21m in financing from SVB, Savitr Capital and other private investors.
– The funding will fuel Glytec’s mission of revolutionizing the role glycemic management plays in the hospital across every department.
– The combined $9m debt financing from SVB and $12m equity investment led by Savitr positions the company to continue its rapid growth by investing in research and development around patient safety, provider workflows and analytics, adding additional talent to its workforce and enhancing integrations with EHRs, mobile apps and other diabetes technology across the continuum of care.
– More than 34m Americans today live with diabetes, 88m live with prediabetes and over one-third of all patients – regardless of a diabetes diagnosis – require insulin during their hospital stay.

Health Care Medical North America Software Therapeutics
Crunchbase icon

Content report

The following text will be sent to our editors: